Chronic NG-nitro-l-arginine methyl ester (L-NAME) administration in C57BL/6J mice induces a sustained decrease in...

Area of Science:

• Cardiovascular Biology
• Cellular Biology
• Molecular Medicine

Background:

• Chronic administration of NG-nitro-l-arginine methyl ester (L-NAME) is a validated rodent model for inducing cardiac hypertrophy.
• The role of c-kit expression in the development of cardiac hypertrophy remains incompletely understood.

Purpose of the Study:

• To investigate the expression patterns of c-kit in the context of L-NAME induced cardiac hypertrophy.
• To elucidate the potential involvement of c-kit positive cells in the pathogenesis of cardiac hypertrophy.

Main Methods:

• C57BL/6J mice were administered L-NAME in drinking water for up to 6 weeks.
• Cardiac hypertrophy was assessed by measuring ventricular wall thickness and cardiomyocyte cross-sectional area.
• Immunohistochemical staining was performed to evaluate c-kit expression in cardiac tissue.

Main Results:

• Six weeks of L-NAME administration resulted in significant cardiac hypertrophy.
• C-kit expression remained stable in the initial 1-2 days of L-NAME treatment but decreased significantly by day 5 and was sustained.
• C-kit positive cells were observed in both control and L-NAME treated mice, with predominant non-mast cell subtypes.

Conclusions:

• The decrease in c-kit expression after 5 days suggests it is not a direct consequence of nitric oxide synthase inhibition.
• The sustained presence of c-kit positive cells despite decreasing expression indicates potential differentiation into other cell types, possibly contributing to myocardial hyperplasia.